Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro
Clinical trial NCT05952453 · RECRUITING
Trial details
- NCT number
- NCT05952453
- Sponsor
- University of Alabama at Birmingham
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-17
- Primary completion
- 2028-10-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.